CoChat

The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies

Open access
Xu, Jun, Liu, Xiao, Koyama, Yukinori, Wang, Ping, Lan, Tian, Kim, In-Gyu, Kim, In H., Ma, Hsiao-Yen, Kisseleva, Tatiana · 2014 · Frontiers in Pharmacology
Cited by 126

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Liver fibrosis results from dysregulation of normal wound healing, inflammation, activation of myofibroblasts, and deposition of extracellular matrix (ECM). Chronic liver injury causes death of hepatocytes and formation of apoptotic bodies, which in turn, release factors that recruit inflammatory cells (neutrophils, monocytes, macrophages, and lymphocytes) to the injured liver. Hepatic macrophages (Kupffer cells) produce TGFβ1 and other inflammatory cytokines that activate Collagen Type I producing myofibroblasts, which are not present in the normal liver. Secretion of TGFβ1 and activation of myofibroblasts play a critical role in the pathogenesis of liver fibrosis of different etiologies. Although the composition of fibrogenic myofibroblasts varies dependent on etiology of liver injury, liver resident hepatic stellate cells and portal fibroblasts are the major source of myofibroblasts in fibrotic liver in both experimental models of liver fibrosis and in patients with liver disease. Several studies have demonstrated that hepatic fibrosis can reverse upon cessation of liver injury. Regression of liver fibrosis is accompanied by the disappearance of fibrogenic myofibroblasts followed by resorption of the fibrous scar. Myofibroblasts either apoptose or inactivate into a quiescent-like state (e.g., stop collagen production and partially restore expression of lipogenic genes). Resolution of liver fibrosis is associated with recruitment of macrophages that secrete matrix-degrading enzymes (matrix metalloproteinase, collagenases) and are responsible for fibrosis resolution. However, prolonged/repeated liver injury may cause irreversible crosslinking of ECM and formation of uncleavable collagen fibers. Advanced fibrosis progresses to cirrhosis and hepatocellular carcinoma. The current review will summarize the role and contribution of different cell types to populations of fibrogenic myofibroblasts in fibrotic liver.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2014.00167

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 146

  1. Asahina, 2002, Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver., Am. J. Pathol., 160, 2191, 10.1016/S0002-9440(10)61167-4 · DOI
  2. Asahina, 2011, Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver., Hepatology, 53, 983, 10.1002/hep.24119 · DOI · Paper page
  3. Baghdasaryan, 2010, Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation., Gut, 59, 521, 10.1136/gut.2009.186528 · DOI
  4. Balmelli, 2007, Responsiveness of fibrocytes to toll-like receptor danger signals., Immunobiology, 212, 693, 10.1016/j.imbio.2007.09.009 · DOI
  5. Balmelli, 2005, Fibrocytes are potent stimulators of anti-virus cytotoxic T cells., J. Leukoc. Biol., 77, 923, 10.1189/jlb.1204701 · DOI
  6. Bataller, 2003, NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis., J. Clin. Invest., 112, 1383, 10.1172/JCI18212 · DOI · Paper page
  7. Bellini, 2007, The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses., Lab. Invest., 87, 858, 10.1038/labinvest.3700654 · DOI · Paper page
  8. Berg, 2007, Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation., Hepatology, 46, 1187, 10.1002/hep.21814 · DOI · Paper page
  9. Bethanis, 2006, Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?, Dig. Dis. Sci., 51, 1685, 10.1007/s10620-006-9126-0 · DOI
  10. Bhunchet, 1992, Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis., Hepatology, 16, 1452, 10.1002/hep.1840160623 · DOI · Paper page
  11. Bosselut, 2010, Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts., Proteomics, 10, 1017, 10.1002/pmic.200900257 · DOI · Paper page
  12. Brenner, 2011, “Contribution of fibrocytes to liver fibrosis: current concept and future prospectives,” in, Fibrocytes in Health and Disease
  13. Brenner, 2012, Origin of myofibroblasts in liver fibrosis., Fibrogenesis Tissue Repair 5(Suppl., 1, 10.1186/1755-1536-5-S1-S17 · DOI · Paper page
  14. Brenner, 1989, Analysis of the collagen alpha 1(I). promoter., Nucleic Acids Res., 17, 6055, 10.1093/nar/17.15.6055 · DOI
  15. Brinkmann, 2004, Neutrophil extracellular traps kill bacteria., Science, 303, 1532, 10.1126/science.1092385 · DOI · Paper page
  16. Bucala, 2008, Circulating fibrocytes: cellular basis for NSF., J. Am. Coll. Radiol., 5, 36, 10.1016/j.jacr.2007.08.016 · DOI
  17. Bucala, 1994, Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair., Mol Med., 1, 71, 10.1007/BF03403533 · DOI · Paper page
  18. Cassiman, 2006, Hepatic stellate cells do not derive from the neural crest., J. Hepatol., 44, 1098, 10.1016/j.jhep.2005.09.023 · DOI
  19. Cassiman, 2002, Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers., J. Hepatol., 36, 200, 10.1016/S0168-8278(01)00260-4 · DOI · Paper page
  20. Chapman, 2007, Ultrastructural features of Glisson’s capsule and the overlying mesothelium in rat, monkey and pike liver., Tissue Cell, 39, 343, 10.1016/j.tice.2007.06.005 · doi:10.1016/j.tice.2007.06.005
  21. Chesney, 1997, The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ., Proc. Natl. Acad. Sci. U.S.A., 94, 6307, 10.1073/pnas.94.12.6307 · DOI · Paper page
  22. Choi, 2009, Epithelial-to-mesenchymal transitions in the liver., Hepatology, 50, 2007, 10.1002/hep.23196 · DOI · Paper page
  23. Chow, 2010, Statins enhance formation of phagocyte extracellular traps., Cell Host Microbe, 8, 445, 10.1016/j.chom.2010.10.005 · DOI · Paper page
  24. Chu, 2011, Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis., Hepatology, 53, 1685, 10.1002/hep.24206 · DOI · Paper page
  25. Clouzeau-Girard, 2006, Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices., Lab. Invest., 86, 275, 10.1038/labinvest.3700386 · DOI
  26. Cowper, 2003, Nephrogenic fibrosing dermopathy: suspect identified, motive unclear., Am. J. Dermatopathol., 25, 10.1097/00000372-200308000-00017 · DOI
  27. Curnow, 2010, Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum., PLoS ONE, 5, 10.1371/journal.pone.0009730 · DOI
  28. De Minicis, 2007, Gene expression profiles during hepatic stellate cell activation in culture and in vivo., Gastroenterology, 132, 1937, 10.1053/j.gastro.2007.02.033 · DOI · Paper page
  29. Deng, 2011, Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia., Dig. Dis. Sci., 56, 731, 10.1007/s10620-010-1347-6 · DOI
  30. Desmouliere, 1997, Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat., Lab. Invest., 76, 765
  31. Dranoff, 2002, The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver., Hepatology, 36, 1135, 10.1053/jhep.2002.36823 · DOI
  32. Dudas, 2007, Thy-1 is an in vivo and in vitro marker of liver myofibroblasts., Cell Tissue Res., 329, 503, 10.1007/s00441-007-0437-z · DOI
  33. Ekert, 2011, Chemokine (C-C motif). ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes., Fibrogenesis Tissue Repair, 10.1186/1755-1536-4-23 · DOI
  34. Enzan, 1994, Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma., Hepatology, 19, 895, 10.1002/hep.1840190415 · DOI · Paper page
  35. Eyden, 2008, The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine., J. Cell. Mol. Med., 12, 22, 10.1111/j.1582-4934.2007.00213.x · DOI · Paper page
  36. Fabris, 2011, Epithelial-mesenchymal interactions in biliary diseases., Semin. Liver Dis., 31, 11, 10.1055/s-0031-1272832 · DOI
  37. Fallowfield, 2007, Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis., J. Immunol., 178, 5288, 10.4049/jimmunol.178.8.5288 · DOI · Paper page
  38. Fausther, 2011, New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice., J. Hepatol., 55, 939, 10.1016/j.jhep.2011.04.013 · DOI
  39. Fausther, 2013, Contribution of myofibroblasts of different origins to liver fibrosis., Curr. Pathobiol. Rep., 1, 225, 10.1007/s40139-013-0020-0 · DOI
  40. Fausther, 2012, Activated hepatic stellate cells upregulate transcription of ecto-5’-nucleotidase/CD73 via specific SP1 and SMAD promoter elements., Am. J. Physiol. Gastrointest. Liver Physiol., 303, G904, 10.1152/ajpgi.00015.2012 · DOI
  41. Fichtner-Feigl, 2006, IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis., Nat. Med., 12, 99, 10.1038/nm1332 · DOI · Paper page
  42. Forbes, 2011, Liver fibrogenic cells., Best Pract. Res. Clin. Gastroenterol., 25, 207, 10.1016/j.bpg.2011.02.006 · DOI
  43. Friedman, 2008b, Mechanisms of hepatic fibrogenesis., Gastroenterology, 134, 1655, 10.1053/j.gastro.2008.03.003 · DOI · Paper page
  44. Friedman, 1985, Hepatic lipocytes: the principal collagen-producing cells of normal rat liver., Proc. Natl. Acad. Sci. U.S.A., 82, 681, 10.1073/pnas.82.24.8681 · DOI · Paper page
  45. Gaca, 2003, Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells., Matrix Biol., 22, 229, 10.1016/S0945-053X(03)00017-9 · DOI
  46. Galan, 2006, Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)., Curr. Opin. Rheumatol., 18, 614, 10.1097/01.bor.0000245725.94887.8d · DOI · Paper page
  47. Giannelli, 2005, Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection., Histol. Histopathol., 20, 939
  48. Gilbertson, 2003, Cre-lox recombination: cre-ative tools for plant biotechnology., Trends Biotechnol., 21, 550, 10.1016/j.tibtech.2003.09.011 · DOI
  49. Goddard, 1998, Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis., Gut, 43, 433, 10.1136/gut.43.3.433 · DOI
  50. Gomperts, 2007, Fibrocytes in lung disease., J. Leukoc. Biol., 82, 449, 10.1189/jlb.0906587 · DOI · Paper page
  51. Goodpaster, 2008, An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue., J. Histochem. Cytochem., 56, 347, 10.1369/jhc.7A7287.2007 · DOI · Paper page
  52. Grieb, 2011, Circulating fibrocytes-biology and mechanisms in wound healing and scar formation., Int. Rev. Cell Mol. Biol., 291, 1, 10.1016/B978-0-12-386035-4.00001-X · DOI
  53. Hao, 2013, Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo., Clin. Exp. Med., 14, 141, 10.1007/s10238-013-0229-6 · DOI
  54. Heinz, 2012, Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies., Curr. Top. Microbiol. Immunol., 356, 1, 10.1007/82_2011_142 · DOI
  55. Henikoff, 2008, Nucleosome destabilization in the epigenetic regulation of gene expression., Nat. Rev. Genet., 9, 15, 10.1038/nrg2206 · DOI · Paper page
  56. Higashiyama, 2009, Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice., Gastroenterology, 137, 1459, 10.1053/j.gastro.2009.07.006 · DOI
  57. Hong, 2007, Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma., J. Biol. Chem., 282, 22910, 10.1074/jbc.M703597200 · DOI · Paper page
  58. Inokuchi, 2011, Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice., Alcohol. Clin. Exp. Res., 35, 1509
  59. Iredale, 2001, Hepatic stellate cell behavior during resolution of liver injury., Semin. Liver Dis., 21, 427, 10.1055/s-2001-17557 · DOI · Paper page
  60. Ishida, 2007, Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration., Am. J. Pathol., 170, 843, 10.2353/ajpath.2007.051213 · DOI · Paper page
  61. Itoh, 2013, Pathophysiological roles of FGF signaling in the heart., Front. Physiol., 4, 10.3389/fphys.2013.00247 · DOI
  62. Iwaisako, 2012, What’s new in liver fibrosis? The origin of myofibroblasts in liver fibrosis., J. Gastroenterol. Hepatol., 65, 10.1111/j.1440-1746.2011.07002.x · DOI · Paper page
  63. Jaster, 2005, Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells., J. Cell Mol. Med., 9, 670, 10.1111/j.1582-4934.2005.tb00497.x · DOI
  64. Jhandier, 2005, Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2., J. Biol. Chem., 280, 22986, 10.1074/jbc.M412371200 · DOI
  65. Ji, 2012, Comparative proteomic analysis of rat hepatic stellate cell activation: a comprehensive view and suppressed immune response., Hepatology, 56, 332, 10.1002/hep.25650 · DOI · Paper page
  66. Jinnin, 2006, Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways., J. Invest. Dermatol., 126, 551, 10.1038/sj.jid.5700090 · DOI
  67. Kallis, 2009, The bone marrow and liver fibrosis: friend or foe?, Gastroenterology, 137, 1218, 10.1053/j.gastro.2009.08.026 · DOI · Paper page
  68. Kalluri, 2009, EMT: when epithelial cells decide to become mesenchymal-like cells., J. Clin. Invest., 119, 1417, 10.1172/JCI39675 · DOI · Paper page
  69. Kalluri, 2003, Epithelial-mesenchymal transition and its implications for fibrosis., J. Clin. Invest., 112, 1776, 10.1172/JCI200320530 · DOI · Paper page
  70. Kessenbrock, 2009, Netting neutrophils in autoimmune small-vessel vasculitis., Nat. Med., 15, 623, 10.1038/nm.1959 · DOI · Paper page
  71. Kisseleva, 2006, Hepatic stellate cells and the reversal of fibrosis., J. Gastroenterol. Hepatol., S84, 10.1111/j.1440-1746.2006.04584.x · DOI · Paper page
  72. Kisseleva, 2007, Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis., J. Gastroenterol. Hepatol., S73, 10.1111/j.1440-1746.2006.04658.x · DOI · Paper page
  73. Kisseleva, 2008a, Fibrogenesis of parenchymal organs., Proc. Am. Thorac. Soc., 5, 338, 10.1513/pats.200711-168DR · DOI · Paper page
  74. Kisseleva, 2008b, Mechanisms of fibrogenesis., Exp. Biol. Med., 233, 109, 10.3181/0707-MR-190 · DOI · Paper page
  75. Kisseleva, 2011, Anti-fibrogenic strategies and the regression of fibrosis., Best Pract. Res. Clin. Gastroenterol., 25, 305, 10.1016/j.bpg.2011.02.011 · DOI · Paper page
  76. Kisseleva, 2012, The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis., J. Hepatol., 56, 965, 10.1016/j.jhep.2011.09.021 · DOI · Paper page
  77. Kisseleva, 2006, Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis., J. Hepatol., 45, 429, 10.1016/j.jhep.2006.04.014 · DOI · Paper page
  78. Kisseleva, 2011, Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection., J. Mol. Med., 89, 997, 10.1007/s00109-011-0756-0 · DOI · Paper page
  79. Kleaveland, 2014, Paracrine functions of fibrocytes to promote lung fibrosis., Expert. Rev. Respir. Med., 8, 163, 10.1586/17476348.2014.862154 · DOI
  80. Knittel, 1999, Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential., Gastroenterology, 117, 1205, 10.1016/S0016-5085(99)70407-5 · DOI · Paper page
  81. Kruglov, 2002, Isolation of primary rat liver fibroblasts., J. Investig. Med., 50, 179, 10.2310/6650.2002.33431 · DOI · Paper page
  82. Lemoinne, 2013, Origins and functions of liver myofibroblasts., Biochim. Biophys. Acta, 1832, 948, 10.1016/j.bbadis.2013.02.019 · DOI
  83. Li, 2007, Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture., Hepatology, 46, 1246, 10.1002/hep.21792 · DOI · Paper page
  84. Lin, 2008, Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney., Am. J. Pathol., 173, 1617, 10.2353/ajpath.2008.080433 · DOI · Paper page
  85. Liu, 2003, Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent., J. Biol. Chem., 278, 11721, 10.1074/jbc.M207728200 · DOI · Paper page
  86. Liu, 2013, Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts., Curr. Pathobiol. Rep., 1, 209, 10.1007/s40139-013-0018-7 · DOI
  87. Magness, 1999, Targeted disruption of the mouse ferrochelatase gene producing an exon 10 deletion., Biochim. Biophys. Acta, 1453, 161, 10.1016/S0925-4439(98)00096-9 · DOI
  88. Magness, 2004, A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations., Hepatology, 40, 1151, 10.1002/hep.20427 · DOI · Paper page
  89. Mair, 2010, Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis., Gastroenterology, 138, 2499, 10.1053/j.gastro.2010.02.049 · DOI
  90. Meurer, 2013, Overexpression of endoglin modulates TGF-beta1-signalling pathways in a novel immortalized mouse hepatic stellate cell line., PLoS ONE, 8, 10.1371/journal.pone.0056116 · DOI
  91. Moore, 2005, CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury., Am. J. Pathol., 166, 675, 10.1016/S0002-9440(10)62289-4 · DOI · Paper page
  92. Moore, 2006, The role of CCL12 in the recruitment of fibrocytes and lung fibrosis., Am. J. Respir. Cell Mol. Biol., 35, 175, 10.1165/rcmb.2005-0239OC · DOI · Paper page
  93. Muhanna, 2008, Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis., Hepatology, 48, 963, 10.1002/hep.22413 · DOI · Paper page
  94. Niedermeier, 2009, CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes., Proc. Natl. Acad. Sci. U.S.A., 106, 17892, 10.1073/pnas.0906070106 · DOI · Paper page
  95. Österreicher, 2011, Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver., Proc. Natl. Acad. Sci. U.S.A., 108, 308, 10.1073/pnas.1017547108 · DOI · Paper page
  96. Parola, 2008, Myofibroblast - like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario., Mol. Aspects Med., 29, 58, 10.1016/j.mam.2007.09.002 · DOI · Paper page
  97. Parsons, 2011, Mutation of the 5’-untranslated region stem-loop structure inhibits alpha1(I). collagen expression in vivo., J. Biol. Chem., 286, 8609, 10.1074/jbc.M110.189118 · DOI
  98. Pepke, 2009, Computation for ChIP-seq and RNA-seq studies., Nat. Methods, 6, S22, 10.1038/nmeth.1371 · DOI · Paper page
  99. Phillips, 2004, Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis., J. Clin. Invest., 114, 438, 10.1172/JCI200420997 · DOI · Paper page
  100. Pilling, 2009, Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts., PLoS ONE, 4, 10.1371/journal.pone.0007475 · DOI · Paper page
  101. Pinzani, 2001, Cytokine receptors and signaling in hepatic stellate cells., Semin. Liver Dis., 21, 397, 10.1055/s-2001-17554 · DOI · Paper page
  102. Pope, 2005, Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation., J. Biol. Chem., 280, 13952, 10.1074/jbc.M406037200 · DOI · Paper page
  103. Quan, 2007, Culture and analysis of circulating fibrocytes., Methods Mol. Med., 135, 423, 10.1007/978-1-59745-401-8_28 · doi:10.1007/978-1-59745-401-8_28
  104. Quan, 2004, Circulating fibrocytes: collagen-secreting cells of the peripheral blood., Int. J. Biochem. Cell Biol., 36, 598, 10.1016/j.biocel.2003.10.005 · DOI · Paper page
  105. Reif, 2003, The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression., J. Biol. Chem., 278, 8083, 10.1074/jbc.M212927200 · DOI · Paper page
  106. Reilkoff, 2011, Fibrocytes: emerging effector cells in chronic inflammation., Nat. Rev. Immunol., 11, 427, 10.1038/nri2990 · DOI · Paper page
  107. Rinkevich, 2012, Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature., Nat. Cell Biol., 14, 1251, 10.1038/ncb2610 · DOI · Paper page
  108. Roderfeld, 2009, Bone marrow transplantation demonstrates medullar origin of CD34(+). fibrocytes and ameliorates hepatic fibrosis in Abcb4(-/-). mice., Hepatology, 51, 267, 10.1002/hep.23274 · DOI
  109. Russo, 2006, The bone marrow functionally contributes to liver fibrosis., Gastroenterology, 130, 1807, 10.1053/j.gastro.2006.01.036 · DOI · Paper page
  110. Sahebally, 2013, Circulating fibrocytes and Crohn’s disease., Br. J. Surg., 100, 1549, 10.1002/bjs.9302 · DOI
  111. Sakai, 2006, Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis., Proc. Natl. Acad. Sci. U.S.A., 103, 14098, 10.1073/pnas.0511200103 · DOI · Paper page
  112. Scholten, 2010, Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice., Gastroenterology, 139, 987, 10.1053/j.gastro.2010.05.005 · DOI · Paper page
  113. Scholten, 2011, Migration of fibrocytes in fibrogenic liver injury., Am. J. Pathol., 179, 189, 10.1016/j.ajpath.2011.03.049 · DOI
  114. Seki, 2009b, CCR2 promotes hepatic fibrosis in mice., Hepatology, 50, 185, 10.1002/hep.22952 · DOI · Paper page
  115. Seki, 2007, TLR4 enhances TGF-beta signaling and hepatic fibrosis., Nat. Med., 13, 1324, 10.1038/nm1663 · DOI · Paper page
  116. She, 2005, Adipogenic transcriptional regulation of hepatic stellate cells., J. Biol. Chem., 280, 4959, 10.1074/jbc.M410078200 · DOI · Paper page
  117. Shimamura, 2008, Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model., J. Immunol., 181, 4656, 10.4049/jimmunol.181.7.4656 · DOI · Paper page
  118. Stefanovic, 2003, 5’ stem-loop of collagen alpha 1(I). mRNA inhibits translation in vitro but is required for triple helical collagen synthesis in vivo., J. Biol. Chem., 278, 927, 10.1074/jbc.M209175200 · DOI · Paper page
  119. Stefanovic, 1997, Posttranscriptional regulation of collagen alpha1(I). mRNA in hepatic stellate cells., Mol. Cell. Biol., 17, 5201, 10.1128/MCB.17.9.5201 · DOI · Paper page
  120. Stefanovic, 2000, The 5’ stem-loop regulates expression of collagen alpha1(I). mRNA in mouse fibroblasts cultured in a three-dimensional matrix., Nucleic Acids Res., 28, 641, 10.1093/nar/28.2.641 · DOI
  121. Stefanovic, 2002, Inhibition of collagen alpha 1(I). expression by the 5’ stem-loop as a molecular decoy., J. Biol. Chem., 277, 18229, 10.1074/jbc.M108065200 · DOI · Paper page
  122. Stefanovic, 2005, Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils., Exp. Biol. Med., 230, 573, 10.1177/153537020523000809 · DOI · Paper page
  123. Strieter, 2007, The role of CXC chemokines in pulmonary fibrosis., J. Clin. Invest., 117, 549, 10.1172/JCI30562 · DOI · Paper page
  124. Strieter, 2009, The role of circulating mesenchymal progenitor cells (fibrocytes). in the pathogenesis of pulmonary fibrosis., J. Leukoc. Biol., 86, 1111, 10.1189/jlb.0309132 · DOI · Paper page
  125. Suzuki, 2008, p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver., Gastroenterology, 135, 270, 10.1053/j.gastro.2008.03.075 · DOI
  126. Taura, 2008, Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis., Gastroenterology, 135, 1729, 10.1053/j.gastro.2008.07.065 · DOI · Paper page
  127. Taura, 2010, Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice., Hepatology, 51, 1027, 10.1002/hep.23368 · DOI · Paper page
  128. Tsukamoto, 2005a, Adipogenic phenotype of hepatic stellate cells., Alcohol. Clin. Exp. Res., 29, 132S, 10.1097/01.alc.0000189279.92602.f0 · DOI
  129. Tsukamoto, 2005b, Fat paradox in liver disease., Keio J. Med., 54, 190, 10.2302/kjm.54.190 · DOI
  130. Tsukamoto, 2011, Epigenetic cell fate regulation of hepatic stellate cells., Hepatol. Res., 41, 675, 10.1111/j.1872-034X.2011.00804.x · DOI · Paper page
  131. Tsukamoto, 2012, Morphogens and hepatic stellate cell fate regulation in chronic liver disease., J. Gastroenterol. Hepatol., 94, 10.1111/j.1440-1746.2011.07022.x · DOI · Paper page
  132. Tuchweber, 1996, Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat., Lab. Invest., 74, 265
  133. Uchinami, 2006, Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis., Hepatology, 44, 420, 10.1002/hep.21268 · DOI · Paper page
  134. Uchio, 2002, Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts., Lab. Invest., 82, 619, 10.1038/labinvest.3780456 · DOI
  135. Venkataraman, 1999, Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex., Proc. Natl. Acad. Sci. U.S.A., 96, 3658, 10.1073/pnas.96.7.3658 · DOI · Paper page
  136. von Kockritz-Blickwede, 2008, Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation., Blood, 111, 3070, 10.1182/blood-2007-07-104018 · DOI · Paper page
  137. Wada, 2007, Fibrocytes: a new insight into kidney fibrosis., Kidney Int., 72, 269, 10.1038/sj.ki.5002325 · DOI
  138. Watsky, 2010, New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies., Int. Rev. Cell. Mol. Biol., 282, 165, 10.1016/S1937-6448(10)82004-0 · DOI
  139. Wells, 2008, The role of matrix stiffness in regulating cell behavior., Hepatology, 47, 1394, 10.1002/hep.22193 · DOI · Paper page
  140. Wells, 2014, The portal fibroblast: not just a poor man’s stellate cell., Gastroenterolog, 147, 41, 10.1053/j.gastro.2014.05.001 · DOI
  141. Wells, 2004, Autocrine release of TGF-beta by portal fibroblasts regulates cell growth., FEBS Lett., 559, 107, 10.1016/S0014-5793(04)00037-7 · DOI · Paper page
  142. Wen, 2012, Isolation of rat portal fibroblasts by in situ liver perfusion., J. Vis. Exp., 64
  143. Yang, 2008, Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers., Stem Cells, 26, 2104, 10.1634/stemcells.2008-0115 · DOI · Paper page
  144. Yang, 2012, Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect., Hepatology, 55, 1271, 10.1002/hep.24792 · DOI
  145. Yata, 2003, DNase I-hypersensitive sites enhance alpha1(I). collagen gene expression in hepatic stellate cells., Hepatology, 37, 267, 10.1053/jhep.2003.50067 · DOI · Paper page
  146. Yovchev, 2009, Thymus cell antigen-1-expressing cells in the oval cell compartment., Hepatology, 50, 601, 10.1002/hep.23012 · DOI

Cited by

See all 126

Metadata

Authors
Xu, J., Liu, X., Koyama, Y., Wang, P., Lan, T., Kim, I.-G., Kim, I. H., Ma, H.-Y., & Kisseleva, T.
Venue
Frontiers in Pharmacology
Published
2014-07-22
Volume
5
Pages
167-167
ISSN
1663-9812 (ISSN-L)
OpenAlex
W2107036592
Cited by
126
References
23
FWCI
6.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. https://app.cochat.ai/papers/10.3389/fphar.2014.00167
The paper
Xu, J., Liu, X., Koyama, Y., Wang, P., Lan, T., Kim, I.-G., Kim, I. H., Ma, H.-Y., & Kisseleva, T. (2014). The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2014.00167

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.